INS and diabetes mellitus: Cell-based therapy helps prevent the autoimmune destruction of β cells in T1DM, while tissue-derived stem cells such as BM-, adipose tissue-, liver- and pancreas-derived stem cells have the ability to generate insulin-producing cells, and to improve diabetes.